Laura Shawver (Silverback Therapeutics)
A longtime Laura Shawver fan calls the serial entrepreneur back to the helm of a biotech upstart
Just a few months after nabbing an $88 million windfall in her payout for Sanofi’s $2.5 billion Synthorx buyout, serial biotech entrepreneur Laura Shawver …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.